AI Proteins
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
20 Overland St, Boston, Massachusetts, 0...Phone Number
(617) 412-6117Website
www.aiproteins.comRevenue
$8.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About AI Proteins
Founded in 2021, AI Proteins is a biotechnology company with a focus on synthetic proteins de novo. The company is headquartered in Andover, MA.Explore more
AI Proteins Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AI Proteins your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
AI Proteins, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if AI Proteins is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at AI Proteins
Earning: See what the market has to say on AI Proteins recently announced quarterly report
Funding: Get notified immidiatlly once AI Proteins has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if AI Proteins had a recent Job posting/layoffs
Product Launch: Get notified when AI Proteins launches new products
Website visits: Recent activity has been detected on your website
Check if AI Proteins has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined AI Proteins as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
AI Proteins is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AI Proteins is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AI Proteins.
AI Proteins financials insights
Gather financial insights about AI Proteins, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$18.2M
2025
Series A
$41.5M
AI Proteins Tech Stack
A closer look at the technologies used by AI Proteins
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Facilities Relocation / Expansion
AI Proteins is planning to move offices in April 2026. The move will impact approximately 38 employees at the existing office located at 20 Overland St, Boston, MA.
Facilities Relocation/Expansion
Funding
Funding
Promotion
Executive Move
Executive Moves, Promotion
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
AI Proteins News & Media
AI Proteins Announces James Bowman as Company's First Chief Technology Officer
BOSTON, August 26, 2025--AI Proteins, a biotech company pioneering a new class of de novo therapeutic miniproteins designed by artificial intelligence, today announced the appointment of Dr. James Bowman, PhD as its first Chief Technology Officer. In this role, James will drive the expansion of the company’s core technology platform, integrating machine learning, synthetic biology, robotics, and large-scale data analysis to create entirely novel protein therapeutics. He previously served as AI PAI Proteins to Present Key Advances in Miniprotein Therapeutics Development at PEGS Boston 2025
BOSTON--(BUSINESS WIRE)--AI Proteins, a biotechnology company pioneering the development of de novo designed miniprotein therapeutics, will be sending four key scientists to present at PEGS Boston 2025, the leading international conference for protein and antibody engineering. At the event, AI Proteins will unveil recent advances across its platform — from high-throughput protein production to the creation of potent therapeutic candidates for metabolic and inflammatory diseases. “We are thrilleAI Proteins CEO Chris Bahl to Speak at TED Main Stage on Next-Generation Miniprotein Therapeutics
BOSTON & VANCOUVER, British Columbia--(BUSINESS WIRE)--AI Proteins, a Boston-based biotech company pioneering the design of novel miniprotein therapeutics, today announced that its President, CEO, and Founder, Chris Bahl, will be speaking on the main stage at the prestigious TED conference in Vancouver, Canada. His talk will focus on the company's groundbreaking work in designing and developing the next generation of miniprotein therapeutics to address a wide range of diseases. Dr. Bahl, a visiAI Proteins Appoints Philip E. Brandish, PhD as Chief Development Officer
BOSTON--(BUSINESS WIRE)--AI Proteins, Inc., a pioneering company utilizing artificial intelligence to design novel miniprotein therapeutics, today announced the appointment of Dr. Philip E. Brandish, PhD as Chief Development Officer (CDO). Dr. Brandish brings vast leadership experience in the life sciences sector, with a proven track record of discovery and development of novel therapeutics, leading program teams from target validation and candidate selection through IND and into clinical proof
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AI Proteins
Sign Up For FreeTo access detailed company insights
Founded in 2021, AI Proteins is a biotechnology company with a focus on synthetic proteins de novo. The company is headquartered in Andover, MA.... Read More
